Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 19 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (11)
P 1 (1)
P 2 (7)

Trial Status

Completed7
Recruiting6
Unknown3
Active Not Recruiting1
Withdrawn1
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT05102019Not ApplicableRecruitingPrimary

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

NCT06571370Not ApplicableCompleted

Wave Crossover ECP Study for Simplified Therapy

NCT05711849Phase 2Recruiting

Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

NCT03455725Not ApplicableActive Not RecruitingPrimary

CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial

NCT04306237Phase 2WithdrawnPrimary

A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina

NCT07048808Phase 2RecruitingPrimary

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

NCT05492110Not ApplicableRecruitingPrimary

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

NCT04892537Not ApplicableUnknownPrimary

Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia and Microvascular Resistance

NCT04606459Not ApplicableRecruiting

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

NCT03218891Not ApplicableCompletedPrimary

Cardiac Rehabilitation in Patients With Refractory Angina

NCT01566175Not ApplicableRecruitingPrimary

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

NCT04368819Phase 2UnknownPrimary

Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms

NCT03991871Not ApplicableUnknown

HARapan kiTa ECP (External Counter Pulsation) Study HARTEC Study

NCT03350737Not ApplicableCompletedPrimary

Coronary Arteriogenetic Heparinized Exercise

NCT01796912Not ApplicableCompletedPrimary

Lipoprotein Apheresis in Refractory Angina Study

NCT01966042Phase 2CompletedPrimary

Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina

NCT01205893Phase 2CompletedPrimary

Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA

NCT00694642Phase 1Completed

Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis

NCT00820586Phase 2SuspendedPrimary

Intramyocardial Delivery of Autologous Bone Marrow

Showing all 19 trials

Research Network

Activity Timeline